Honasa Consumer Ltd Q2 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/9fiho8y6x3dqfnx3ba3az2ag.pdf

Key Takeaways


Growth & Revenue Drivers

Varun Alagh: "I would rather want to play the long-term strong compounding growth story and continue to build this, deliver marketing leading growth for years to come. Rather than just look at the next two years, this is how I would sort of position us."

Brand Portfolio & Scaling Playbook

Varun Alagh: "This is specifically heartening for us because we acquired Dr. Sheth in early 2022, and we've grown it 30 times to take it to this number, and it just gives us confidence that not only do we have the capability to apply our playbooks to brands that we launch, but also to mixes that we acquire."

Margin Structure & Sustainability

Varun Alagh: "What we're saying is all of that we're seeing is not timing, but scale and structural impact on the business, because of which we are seeing this improved profitability and the Half one level profitability that you see is something which we believe is fairly sustainable."

Operating Model & Infrastructure

Varun Alagh: "Because over time, there are two things that happen. One, our understanding of media mix efficiency improves. Because we have more data after doing so much media on a brand, we know which part of the media mix works harder, because of which we are able to keep the brand spend at that a certain value number and deliver the same kind of growth with that and as we deliver that growth, the percentage wise, it actually goes down."

Guidance & Commitments

CommitmentSpecificsTimeline
Growth benchmarkDeliver ~30%+ growth (H1 level)Short term
Margin improvementContinue to find leverage opportunities; levels discussed "probably even better than that as we grow"Annual endeavor, no specific cadence committed
Ad-spend leverageAd spend as % of revenue to continue declining as revenues grow faster than marketing spendOver years to come
Brand profitability trajectoryYounger brands (Derma Co., Aqualogica, Dr. Sheth's, BBLUNT) to follow Mamaearth's profitability pathOver the next few years
InnovationContinue to innovate every quarter in line with consumer needsOngoing, quarterly cadence
DistributionContinue to gain market share in categories beyond shampoos and face washesOngoing

Key Metrics

MetricQ2 FY24
Revenue from operations₹496 cr, +21% YoY; +24% like-for-like excluding scaled-down services
Gross margin~70%, industry-leading
EBITDA~8%, ~₹40 cr
EBITDA margin (H1 FY24)7.2%, improved 531 bps YoY from 1.9% in H1 FY23
PAT₹29 cr, 5.9% margin
PAT (H1 FY24)~₹54 cr, almost 14x H1 FY23 PAT
Free cash flow₹41 cr, vs PAT of ₹29 cr
Working capitalMinus 5 days
H1 FY24 revenue growth33% YoY; 36% like-for-like
H1 FY24 growth vs FMCG BPC peers3.8x the average industry growth
Offline distribution outlets1.65 lakh, +47% YoY
Mamaearth exclusive stores97
Quick commerce growth100%+ YoY
Innovation contribution to H1 FY24 revenue13%
The Derma Co. annual run rate₹380 cr
Aqualogica annual run rate₹180 cr, achieved in 19 months
Dr. Sheth’s annual run rate₹150 cr, grown 30x since acquisition in early 2022
BBLUNT product business growth since acquisition~300%
Mamaearth offline market share gain in shampoos50 bps
Mamaearth offline market share gain in face washes100 bps
Mamaearth brand searches growth+16%
H1 online channel growth40%
H1 offline channel growth33%
Employee expenses₹37.1 cr; adjusted ~₹41.86 cr after adding back ₹4.7 cr Momspresso ESOP reversal
ESOP expenses (regular, as % of sales)0.7% to 0.8%
Services revenue (H1 FY24)~₹18.5 cr, 2% of company revenue
BBLUNT salon business EBITDA margin20%
One-time derivative liability reversal (standalone)₹10 cr, related to Momspresso
Mamaearth ad spend vs company average~500 bps lower
Trees planted (Plant Goodness initiative)~5,10,000
Plastic recycled since FY217,591 metric tons